News Stories

• Bariatric Surgery Helped Manage Uncontrolled Type 2 Diabetes

  In obese patients with uncontrolled type 2 diabetes, 12 months of medical therapy plus bariatric surgery yielded greater glycemic control than medical therapy alone, according to a study in the emNew England Journal of Medicine...  more >

• Bascom Palmer Eye Institute Added as Site for Stem Cell Clinical Trial for Dry AMD

  Advanced Cell Technology Inc., announced that the Bascom Palmer Eye Institute in Miami has received institutional review board approval as a site for the company’s phase 1/2 clinical trial for dry AMD using human embryonic s...  more >

• Bausch + Lomb to Acquire Ista Pharmaceuticals for $500 Million

  Bausch + Lomb has announced that it will purchase Ista Pharmaceuticals, Inc., in a deal reported to be worth about $500 million. Under the terms to the agreement, which is expected to close in the second quarter of 2012, Bausch...  more >

• Bevacizumab Improved Visual Acuity, Reduced Macular Edema

  Intraocular injections of bevacizumab (Avastin, Genentech) administered every 6 weeks for 6 months improved visual acuity in patients with macular edema secondary to central retinal vein occlusion (CRVO), according to a study ...  more >

• CDC Estimates 1 in 88 US Children Has an Autism Spectrum Disorder

  The US Centers for Disease Control and Prevention (CDC) estimates that 1 in 88 children in the United States has been identified as having an autism spectrum disorder, according to a CDC report,1 the results of which were desc...  more >

• Depression Common Among Patients With Stroke, TIA

  Individuals who have had a stroke or transient ischemic attack (TIA) may have higher rates of depression, according to a study published in emStroke/em.sup1/sup Daniel T. Laskowitz, MD, MHS, of Duke University Medical Center...  more >

• FDA Adds New Safety Warnings to Statin Labels

  The US Food and Drug Administration (FDA) announced that important safety changes will be made to the labeling of statins, according to a news release. In reviewing the statin labels, the FDA concluded that serious liver inj...  more >

• Fluoroquinolones May Slightly Increase Risk of Retinal Detachment

  Patients receiving oral fluoroquinolones may be at a slightly increased risk of developing a retinal detachment, according to a study in the emJournal of the American Medical Association/em./sup1/sup Mahyar Etminan, PharmD, ...  more >

• iCo Therapeutics and JDRF Team Up to Support Clinical Trial for DME

  iCo Therapeutics and JDRF, a foundation that funds type 1 diabetes research, have partnered to investigate a potential new treatment for diabetic macular edema (DME), according to a company news release. The iDEAL study is a...  more >

• Letters

  h4To the Editor:/h4 I thoroughly enjoyed Mike Lambert’s piece about the beginnings of the Vail Vitrectomy Meeting in the January/February issue of emRetina Today/em. It was well written and the pictures and historical docu...  more >

• MacuClear Inc., to Begin Phase 3 Study of Compound for AMD

  MacuClear Inc., announced it will begin phase 3 studies of its lead compound, MC-1101, for early-stage dry AMD, according to a company news release. PMC-1101 is a proprietary, topically administered eye drop formulated to tr...  more >

• Mammography Plus Ultrasound Effective in Detecting Invasive Breast Cancers

  Annual mammography plus ultrasound exams detect 34% more invasive breast cancers than mammography alone, according to a study in the emJournal of the American Medical Association/em.sup1/sup Wendie A. Berg, MD, PhD, of the U...  more >

• Omega-3 Consumption May Slow Progression of Retinitis Pigmentosa

  Among patients with retinitis pigmentosa (RP) receiving vitamin A, those who consumed a diet rich in omega-3 fatty acids had slower rates of visual decline than those who did not, according to a study in Archives of Ophthalmol...  more >

• ThromboGenics Sells Commercialization Rights for Ocriplasmin outside the United States to Alcon

  In a deal worth up to $490 million, ThromboGenics NV announced that it has entered into an agreement with Alcon Laboratories Inc., for exclusive commercialization rights of ocriplasmin (microplasmin) in all markets outside the...  more >